BR9814467A - Mistura graxa - Google Patents
Mistura graxaInfo
- Publication number
- BR9814467A BR9814467A BR9814467-7A BR9814467A BR9814467A BR 9814467 A BR9814467 A BR 9814467A BR 9814467 A BR9814467 A BR 9814467A BR 9814467 A BR9814467 A BR 9814467A
- Authority
- BR
- Brazil
- Prior art keywords
- fatty acids
- fat blend
- linolenic
- gamma
- eicosapentaenoic
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 239000004519 grease Substances 0.000 title 1
- 235000019197 fats Nutrition 0.000 abstract 4
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 3
- 229930195729 fatty acid Natural products 0.000 abstract 3
- 239000000194 fatty acid Substances 0.000 abstract 3
- 150000004665 fatty acids Chemical class 0.000 abstract 3
- OPGOLNDOMSBSCW-CLNHMMGSSA-N Fursultiamine hydrochloride Chemical compound Cl.C1CCOC1CSSC(\CCO)=C(/C)N(C=O)CC1=CN=C(C)N=C1N OPGOLNDOMSBSCW-CLNHMMGSSA-N 0.000 abstract 2
- 235000005911 diet Nutrition 0.000 abstract 2
- 230000000378 dietary effect Effects 0.000 abstract 2
- JIWBIWFOSCKQMA-UHFFFAOYSA-N stearidonic acid Natural products CCC=CCC=CCC=CCC=CCCCCC(O)=O JIWBIWFOSCKQMA-UHFFFAOYSA-N 0.000 abstract 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 abstract 1
- 208000017667 Chronic Disease Diseases 0.000 abstract 1
- 230000001684 chronic effect Effects 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 235000020673 eicosapentaenoic acid Nutrition 0.000 abstract 1
- 235000013305 food Nutrition 0.000 abstract 1
- 235000020664 gamma-linolenic acid Nutrition 0.000 abstract 1
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract 1
- 230000036737 immune function Effects 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 229940067606 lecithin Drugs 0.000 abstract 1
- 235000010445 lecithin Nutrition 0.000 abstract 1
- 239000000787 lecithin Substances 0.000 abstract 1
- 230000037356 lipid metabolism Effects 0.000 abstract 1
- 230000002366 lipolytic effect Effects 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 229940127557 pharmaceutical product Drugs 0.000 abstract 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pediatric Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Obesity (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Edible Oils And Fats (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Fats And Perfumes (AREA)
- Lubricants (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Patente de Invenção: <B>"MISTURA GRAXA"<D>. é preparada uma mistura graxa à base de óleos, graxas e/ou lecitinas com um teor de ácidos graxos várias vezes insaturados. Esta mistura graxa destaca-se pelo fato, de que os ácido graxos ácido gamalinolênico, ácido estearidónico e ácido eicosapentaênico perfazem juntos 10 até 500 mg/g de ácidos graxos totais e o ácido gama-linolênico e o ácido eicosapentaênico perfazem em cada caso 20 até 50%, em peso e o ácido estearidónico perfaz 15 até 50%, em peso, da soma destes ácidos graxos. Esta mistura graxa também pode ser incorporada em um agente farmacêutico, especialmente em um alimento dietético e serve especialmente para a administração em pacientes com doenças inflamatórias/crónicas, com perturbações do metabolismo graxo, com função imunológica enfraquecida e/ou com capacidade lipolítica limitada do trato gastrintestinal.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19757414A DE19757414A1 (de) | 1997-12-23 | 1997-12-23 | Fettmischung |
PCT/EP1998/008409 WO1999033355A2 (de) | 1997-12-23 | 1998-12-22 | Fettmischung |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9814467A true BR9814467A (pt) | 2000-10-10 |
Family
ID=7853100
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9814467-7A BR9814467A (pt) | 1997-12-23 | 1998-12-22 | Mistura graxa |
Country Status (15)
Country | Link |
---|---|
US (1) | US7045143B1 (pt) |
EP (1) | EP1041896B1 (pt) |
JP (1) | JP2001526908A (pt) |
CN (1) | CN1091363C (pt) |
AT (1) | ATE213391T1 (pt) |
AU (1) | AU758079B2 (pt) |
BR (1) | BR9814467A (pt) |
CA (1) | CA2316298C (pt) |
DE (2) | DE19757414A1 (pt) |
DK (1) | DK1041896T3 (pt) |
ES (1) | ES2173673T3 (pt) |
HK (1) | HK1033541A1 (pt) |
NO (1) | NO316302B1 (pt) |
NZ (1) | NZ505608A (pt) |
WO (1) | WO1999033355A2 (pt) |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19757414A1 (de) | 1997-12-23 | 1999-07-01 | Nutricia Nv | Fettmischung |
DE19914104A1 (de) * | 1999-03-23 | 2000-09-28 | Siegfried Seifert | Verfahren zur Verbesserung der körperlichen Erscheinung eines Menschen unter Verabreichung einer Fett-Eiweiß-Diät |
US6340705B1 (en) * | 1999-09-10 | 2002-01-22 | Monsanto Technology, Llc | Use of α-linolenic acid metabolites for treatment or prevention of cancer |
WO2001024812A1 (en) * | 1999-10-06 | 2001-04-12 | N.V. Nutricia | USE OF TRANSFORMING GROWTH FACTOR β AND GROWTH FACTORS IN THE TREATMENT AND PREVENTION OF DISEASES OF THE INTESTINAL MUCOSA |
GB0016045D0 (en) | 2000-06-29 | 2000-08-23 | Laxdale Limited | Therapeutic combinations of fatty acids |
US6667064B2 (en) * | 2000-08-30 | 2003-12-23 | Pilot Therapeutics, Inc. | Composition and method for treatment of hypertriglyceridemia |
EP2275101A1 (en) * | 2001-05-14 | 2011-01-19 | Martek Biosciences Corporation | Polar lipid-rich fraction containing stearidonic acid and gamma linolenic acid from plant seeds and microbes, and its uses |
WO2002092779A2 (en) * | 2001-05-17 | 2002-11-21 | Pilot Therapeutics, Inc. | Method for enriching tissues in long chain polyunsaturated fatty acids |
EP1489915A4 (en) * | 2002-03-08 | 2005-09-14 | Monsanto Technology Llc | TREATMENT AND PREVENTION OF INFLAMMATORY DISORDERS |
DE10254584A1 (de) * | 2002-11-22 | 2004-06-09 | HORST HEIRLER PROJEKTE für Ernährung, Medizin, Ökologie | Verwendung von mittelkettigen Triglyceriden (MCT) zur ernährungsphysiologischen Optimierung des Fettsäurenspektrums in einem diätetischen Lebensmittel für Diabetiker |
DE10361667A1 (de) * | 2003-12-30 | 2005-07-28 | Omega For Life Gmbh | Neuartige Fettpulver |
EP1723951A1 (en) * | 2005-04-21 | 2006-11-22 | N.V. Nutricia | Nutritional supplement with oligosaccharides for a category of HIV patients |
EP1811867A2 (en) * | 2004-11-12 | 2007-08-01 | N.V. Nutricia | Food composition comprising a protein- and a lipid fraction for rapidly attenuating inflammatory responses |
US20090318394A1 (en) * | 2004-11-19 | 2009-12-24 | Julie Nauroth | Long Chain Polyunsaturated Fatty Acids and Methods of Making and Using the Same |
BRPI0516803A (pt) | 2004-11-19 | 2008-09-23 | Martek Biosciences Corp | oxilipinas de ácidos graxos polinsaturados de cadeia longa e métodos de produção e uso dos mesmos |
US7893106B2 (en) * | 2004-11-19 | 2011-02-22 | Martek Biosciences, Corporation | Oxylipins from stearidonic acid and γ-linolenic acid and methods of making and using the same |
WO2007063143A1 (es) * | 2005-11-30 | 2007-06-07 | Katry Inversiones, S.L. | Mezcla de lipidos y su utilización para preparar un producto destinado a la adminitracion enteral u oral |
ATE509624T1 (de) | 2005-12-23 | 2011-06-15 | Nutricia Nv | Zusammensetzung enthaltend mehrfach ungesättigte fettsäuren, proteine, mangan und/oder molybden und nukleotide/nukleoside, zur behandlung von demenz |
US20090320148A1 (en) * | 2006-01-31 | 2009-12-24 | Martek Biosciences Corporation | Oxylipins from stearidonic acid and gamma-linolenic acid and methods of making and using the same |
WO2007121273A2 (en) * | 2006-04-11 | 2007-10-25 | Martek Biosciences Corporation | Food products comprising long chain polyunsaturated fatty acids and methods for preparing the same |
GB0612671D0 (en) * | 2006-06-27 | 2006-08-09 | Shs Int Ltd | Nutritional formulation |
US20080089981A1 (en) * | 2006-10-17 | 2008-04-17 | N.V. Nutricia | Ketogenic diet |
CA2567879C (en) * | 2006-11-14 | 2013-03-26 | Thomas Greither | Nutritional food oil compositions and methods of making same |
GB2444896B (en) * | 2006-12-18 | 2010-05-19 | Nutraceuticals Ltd | Compositions comprising polyunsaturated fatty acids |
JP2010519311A (ja) * | 2007-02-20 | 2010-06-03 | マーテック バイオサイエンシーズ コーポレーション | 長鎖多価不飽和脂肪酸由来のオキシリピンならびにその作製およびその使用方法 |
WO2008147562A2 (en) * | 2007-05-25 | 2008-12-04 | Childrens's Medical Center Corporation | Dietary formulations and methods for treatment of inflammation and other disorders |
CN101820754A (zh) * | 2007-10-04 | 2010-09-01 | 雀巢产品技术援助有限公司 | 用于增强认知功能的组合物与方法 |
BRPI0819732B1 (pt) * | 2007-11-29 | 2019-05-07 | Monsanto Technology Llc | Produto de carne compreendendo óleo endógeno, ácido araquidônio (aa), ácido alfa-linolênico (ala), e ácido estearidônico (sda) |
WO2009086281A1 (en) * | 2007-12-21 | 2009-07-09 | Martek Biosciences Corporation | Method for preparation of oxylipins |
US20100266746A1 (en) * | 2009-04-16 | 2010-10-21 | Monsanto Technology Llc | Spread formulations including stearidonic acid |
CA2767396A1 (en) * | 2009-07-15 | 2011-01-20 | Solae, Llc | Omega-3 fatty acid enriched soups and sauces |
CA2773793A1 (en) * | 2009-09-30 | 2011-04-07 | Solae, Llc | Omega-3 fatty acid enriched shortenings and nut butters |
WO2011071365A1 (en) * | 2009-12-07 | 2011-06-16 | N.V. Nutricia | Balanced fat composition and use thereof in a liquid nutritional composition suitable for enteral feeding |
WO2011091019A1 (en) * | 2010-01-19 | 2011-07-28 | University Of Tennessee Research Foundation | Methods and compositions for treating and preventing parenteral nutrition associated liver disease |
US8372465B2 (en) | 2010-02-17 | 2013-02-12 | Bunge Oils, Inc. | Oil compositions of stearidonic acid |
WO2012092086A1 (en) | 2010-12-29 | 2012-07-05 | Abbott Laboratories | Methods for improving tolerance, digestion, and lipid soluble nutrient absorption in an infant, toddler, or child |
US20120252888A1 (en) * | 2011-03-29 | 2012-10-04 | Palupa Medical Ltd. | Compositions and Methods for Treating Neurologic Disorders |
WO2012138212A1 (en) | 2011-04-06 | 2012-10-11 | N.V. Nutricia | Food composition for intra-operative tube feeding |
US8728546B1 (en) | 2013-03-15 | 2014-05-20 | Swing Aerobics Licensing, Inc. | Medicament for treatment of cancer, cardiovascular diseases and inflammation |
US20150157048A1 (en) * | 2013-12-11 | 2015-06-11 | Mead Johnson Nutrition Company | Nutritional compositions containing stearidonic acid and uses thereof |
US11419350B2 (en) | 2016-07-01 | 2022-08-23 | Corbion Biotech, Inc. | Feed ingredients comprising lysed microbial cells |
CN109527123A (zh) * | 2018-12-14 | 2019-03-29 | 大连大学 | 一种对慢性肠炎具有改善作用的调和油 |
CN112891304B (zh) * | 2020-10-14 | 2022-06-10 | 麦孚营养科技有限公司 | 一种高能量密度的脂肪乳剂及其制备方法和其应用 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3924607A1 (de) | 1989-07-21 | 1991-01-24 | Singer Peter Dr Sc Med | Diaetetisches nahrungs- oder genussmittel |
DK0457950T3 (da) * | 1990-05-23 | 1994-03-07 | Nestle Sa | Anvendelse af stearidonsyre til behandling af inflammatorisk betingede sygdomme |
GB9026648D0 (en) * | 1990-12-07 | 1991-01-23 | Efamol Holdings | Nutrition |
US5922345A (en) * | 1990-12-07 | 1999-07-13 | Scotia Holdings Plc | Nutrition |
US5223285A (en) * | 1992-03-31 | 1993-06-29 | Abbott Laboratories | Nutritional product for pulmonary patients |
AU683027B2 (en) * | 1993-01-27 | 1997-10-30 | Scotia Holdings Plc | Triglycerides |
CA2119000A1 (en) | 1993-03-19 | 1994-09-20 | David Frederick Horrobin | Formulation for use in smokers |
US5714472A (en) | 1993-12-23 | 1998-02-03 | Nestec Ltd. | Enternal formulation designed for optimized nutrient absorption and wound healing |
GB9506837D0 (en) * | 1995-04-03 | 1995-05-24 | Scotia Holdings Plc | Triglycerides |
DE19528461A1 (de) | 1995-08-03 | 1997-02-06 | Braun Melsungen Ag | Präparat zur Ernährung |
EP2260716B1 (en) * | 1996-03-26 | 2014-02-12 | DSM IP Assets B.V. | Late addition of PUFA in infant formula preparation process |
US6077828A (en) * | 1996-04-25 | 2000-06-20 | Abbott Laboratories | Method for the prevention and treatment of cachexia and anorexia |
ES2179156T3 (es) * | 1996-11-20 | 2003-01-16 | Nutricia Nv | Composicion nutricional que incluye grasas para el tratamiento del sindrome metabolico. |
DE19757414A1 (de) | 1997-12-23 | 1999-07-01 | Nutricia Nv | Fettmischung |
-
1997
- 1997-12-23 DE DE19757414A patent/DE19757414A1/de not_active Withdrawn
-
1998
- 1998-12-22 EP EP98966662A patent/EP1041896B1/de not_active Expired - Lifetime
- 1998-12-22 NZ NZ505608A patent/NZ505608A/xx not_active IP Right Cessation
- 1998-12-22 ES ES98966662T patent/ES2173673T3/es not_active Expired - Lifetime
- 1998-12-22 DE DE59803153T patent/DE59803153D1/de not_active Expired - Lifetime
- 1998-12-22 AT AT98966662T patent/ATE213391T1/de active
- 1998-12-22 US US09/581,520 patent/US7045143B1/en not_active Expired - Fee Related
- 1998-12-22 BR BR9814467-7A patent/BR9814467A/pt not_active Application Discontinuation
- 1998-12-22 AU AU24162/99A patent/AU758079B2/en not_active Ceased
- 1998-12-22 JP JP2000526127A patent/JP2001526908A/ja active Pending
- 1998-12-22 CN CN98812474A patent/CN1091363C/zh not_active Expired - Fee Related
- 1998-12-22 CA CA002316298A patent/CA2316298C/en not_active Expired - Fee Related
- 1998-12-22 WO PCT/EP1998/008409 patent/WO1999033355A2/de active IP Right Grant
- 1998-12-22 DK DK98966662T patent/DK1041896T3/da active
-
2000
- 2000-06-22 NO NO20003265A patent/NO316302B1/no not_active IP Right Cessation
-
2001
- 2001-04-11 HK HK01102614A patent/HK1033541A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE59803153D1 (de) | 2002-03-28 |
NO316302B1 (no) | 2004-01-12 |
NO20003265L (no) | 2000-06-22 |
DE19757414A1 (de) | 1999-07-01 |
EP1041896A2 (de) | 2000-10-11 |
CN1282223A (zh) | 2001-01-31 |
AU2416299A (en) | 1999-07-19 |
HK1033541A1 (en) | 2001-09-07 |
ATE213391T1 (de) | 2002-03-15 |
AU758079B2 (en) | 2003-03-13 |
WO1999033355A3 (de) | 1999-09-16 |
DK1041896T3 (da) | 2002-06-17 |
CN1091363C (zh) | 2002-09-25 |
CA2316298C (en) | 2008-11-18 |
CA2316298A1 (en) | 1999-07-08 |
NO20003265D0 (no) | 2000-06-22 |
JP2001526908A (ja) | 2001-12-25 |
US7045143B1 (en) | 2006-05-16 |
ES2173673T3 (es) | 2002-10-16 |
EP1041896B1 (de) | 2002-02-20 |
WO1999033355A2 (de) | 1999-07-08 |
NZ505608A (en) | 2002-12-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20003265D0 (no) | Fettblanding | |
DiGiacomo et al. | Fish-oil dietary supplementation in patients with Raynaud's phenomenon: a double-blind, controlled, prospective study | |
EP1296670B1 (en) | Therapeutic combinations of fatty acids | |
Nordström et al. | Alpha-linolenic acid in the treatment of rheumatoid arthritis. A double-blind, placebo-controlled and randomized study: flaxseed vs. safflower seed | |
DK1121115T4 (da) | PUFA-tilskud | |
US5059622A (en) | Method for reducing blood pressure levels in hypertensive persons | |
EP0815735A3 (fr) | Produit laitier diététiquement équilibré | |
SG64864A1 (en) | Phospholipids | |
KR940018091A (ko) | 불포화 지방산을 포함하는 처방 | |
MXPA03001796A (es) | Composicion y metodo para el tratamiento de hipertrigliceridemia. | |
JPH08500332A (ja) | 炎症性疾患の治療のための非経口的に投与される医薬を調製するためのエマルジョンの使用 | |
Peck | Essential fatty acid deficiency in renal failure: can supplements really help? | |
AU1489688A (en) | Omega-3 fatty acids in traumatic injury treatment | |
JP2537645B2 (ja) | 薬剤的活性を有する栄養組成物 | |
Ling et al. | Early development of essential fatty acid deficiency in rats: fat-free vs. hydrogenated coconut oil diet | |
CA1334002C (en) | Essential fatty acid compositions and methods for the modulation of prostaglandin levels in mammals | |
AU608571B2 (en) | Composition and method for treatment of peptic ulcers | |
Tamargo et al. | Pharmacokinetics and safety profile of omega-3 polyunsaturated fatty acids | |
Maki et al. | Bioavailability of eicosapentaenoic and docosahexaenoic n‐3 polyunsaturated fatty acids in salmon patties compared with capsules | |
US11617732B2 (en) | Composition for improving vascular endothelial function | |
Olafsson et al. | Dietary cod liver oil decreases arachidonic acid in rat gastric mucosa and increases stress-induced gastric erosions | |
Llor et al. | The effect of olive oil on inflammatory bowel disease. | |
Houston | The Use of Fish Oil Supplements in Clinical Practice: A Review | |
Tamura et al. | АА EPA DPA DHA PC before after | |
Boissonneault | Dietary Fat, Immunity, and In> ammatory Disease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O COMBINADO COM ART. 13 DA LPI |
|
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL. |
|
B15K | Others concerning applications: alteration of classification |
Ipc: A23D 9/00 (2006.01), A23L 33/115 (2016.0 |